Ikena Oncology, Inc. (NASDAQ:IKNA – Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 215,300 shares, a decrease of 22.9% from the May 31st total of 279,400 shares. Currently, 1.0% of the company’s stock are sold short. Based […]
Ikena Oncology, Inc. (NASDAQ:IKNA – Get Rating) – Equities research analysts at HC Wainwright issued their Q1 2023 earnings per share estimates for Ikena Oncology in a report released on Thursday, May 4th. HC Wainwright analyst A. Maldonado anticipates that the company will earn ($0.41) per share for the quarter. HC Wainwright has a “Buy” […]
HC Wainwright reiterated their buy rating on shares of Ikena Oncology (NASDAQ:IKNA – Get Rating) in a research report sent to investors on Thursday, MarketBeat reports. HC Wainwright currently has a $18.00 price objective on the stock. Separately, Credit Suisse Group cut their price objective on shares of Ikena Oncology from $16.00 to $13.00 and […]
Ikena Oncology, Inc. (NASDAQ:IKNA – Get Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 465,600 shares, a growth of 33.2% from the March 31st total of 349,500 shares. Approximately 1.8% of the shares of the stock are sold short. Based on […]
Ikena Oncology (NASDAQ:IKNA – Get Rating) and Icosavax (NASDAQ:ICVX – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Risk and Volatility Ikena Oncology has a beta of 0.75, […]